Quick answer: Most synthetic peptides leave the lab as salts. The cationic sites on the peptide, such as the free N-terminus, Lys, Arg and His, are paired with anions. Trifluoroacetate (TFA) is the default counter-ion because trifluoroacetic acid is used both to cleave the peptide from the resin in solid-phase synthesis and in the HPLC mobile phase. Acetate or chloride appear only when someone deliberately exchanges the counter-ion. The salt changes how much of each milligram is actually peptide. By our calculations that is roughly 14–50% of the mass for the peptides tabled below. It can also change cell-assay readouts. HPLC purity cannot see either effect. Only a counter-ion assay, a water assay and a net peptide content figure can.

Key takeaways
- TFA salts are the normal result of Fmoc solid-phase synthesis and reverse-phase HPLC, not a sign of a poor batch[1][2].
- Counter-ion load scales with the number of positive charges. Measured TFA has reached 10–35% w/w and can exceed the 1:1 charge stoichiometry because unbound TFA is retained[2][3][5].
- HPLC purity is not peptide content. In one mass-balance study glucagon was 98.4% pure by LC-UV but only 89.6% peptide by mass once TFA and water were counted[5].
- Counter-ion effects on cells are real but case-specific. TFA at 10−8–10−7 M reduced rat osteoblast cell numbers in one study, yet in another TFA was not the most cytotoxic salt for every peptide[3][7].
- Exchange to chloride with dilute HCl is well characterised. Acetate exchange by simple lyophilisation is unreliable, and acetate can be lost on freeze-drying[2][4][6][8].
- A useful COA names the counter-ion, gives its content and the method used (19F NMR, IC, ELSD or CE), and reports water and net peptide content.
Why synthetic peptides are TFA salts by default
In Fmoc solid-phase peptide synthesis (SPPS) the finished chain is released from the resin, and its side-chain protecting groups are removed, with a cocktail that is mostly trifluoroacetic acid. Preparative reverse-phase HPLC then commonly uses 0.1% TFA as an ion-pairing agent. The peptide therefore leaves purification surrounded by trifluoroacetate. Every protonated amine or guanidine group pairs with a CF3COO− anion[1][2]. Sikora and colleagues’ review describes TFA as present in two forms: ionically bound to the cationic sites and free or adsorbed. Lyophilisation removes part of the free acid but not the bound counter-ion[1].
Erckes et al. saw this directly. Their peptide AT1 still held 0.333 mg TFA per mg after purification. A control run through the exchange workflow with plain water (0 mM HCl) dropped it to 0.215 mg/mg, which shows how much of the original load was loosely held excess acid[2]. Glucagon in a separate study carried 3.51 TFA per molecule. That figure is calculated from 103.03 mg/g TFA. Glucagon has five basic sites, so the load was below the charge maximum[5]. So the real counter-ion load can sit above or below the theoretical figure, and it has to be measured.
Most approved peptide drugs are acetate salts, and a few are TFA or chloride salts. The review lists bivalirudin and corticorelin among the TFA examples[1]. Salt choice is a formulation decision. It does not change the peptide’s identity, unlike the terminal caps discussed in Semax vs N-acetyl Semax amidate.
How much of a milligram is counter-ion? (calculated)
Theoretical counter-ion content = n × Macid ÷ (Mfree base + n × Macid). Here n is the number of protonatable sites at acidic pH, i.e. the N-terminal amine plus Lys, Arg and His. We use the acid masses TFA 114.02, acetic acid 60.05 and HCl 36.46 g/mol[9][10]. Some vendor calculators use the anion mass (113 or 59) instead. The difference is under 0.2 percentage points, so either is acceptable as long as the method is stated.
| Peptide (free base MW) | Basic sites n | TFA salt, % counter-ion | Acetate salt, % | HCl salt, % | Peptide nmol per mg: free base / TFA / acetate / HCl |
|---|---|---|---|---|---|
| GHK (340.38) | 3 | 50.1 | 34.6 | 24.3 | 2938 / 1465 / 1921 / 2223 |
| Selank (751.87) | 3 | 31.3 | 19.3 | 12.7 | 1330 / 914 / 1073 / 1161 |
| Semax (813.93) | 2 | 21.9 | 12.9 | 8.2 | 1229 / 960 / 1071 / 1128 |
| BPC-157 (1419.53) | 2 | 13.8 | 7.8 | 4.9 | 704 / 607 / 650 / 670 |
| Citropin 1.1 amide (1614.9) | 3 | 17.5 | 10.0 | 6.3 | 619 / 511 / 557 / 580 |
| Glucagon (3482.75) | 5 | 14.1 | 7.9 | 5.0 | 287 / 247 / 264 / 273 |
Two patterns stand out. Small, basic peptides are hit hardest: a full TFA salt of GHK is half counter-ion by mass. And the same weighed milligram can hold about 1.3–1.5× more peptide molecules as an HCl salt than as a TFA salt, depending on the peptide (calculated). For a generic 1,000 Da peptide, TFA makes up 10.2, 18.6, 25.5, 31.3, 36.3 and 40.6% of the mass with 1–6 basic sites (calculated). Measured data agree with this range. Erckes et al. expected about 25% TFA for their model peptides and measured up to 35%[2]. Sikora et al. measured 150–320 µg TFA per mg across antimicrobial peptides by ion chromatography[3].
The excess can be estimated. AT1’s chloride content after exchange, 9.8% (99% of stoichiometric), implies about 325 Da of peptide per positive charge. That predicts 26.0% TFA, against 33.3% measured, or about 1.28× the stoichiometric amount (calculated from[2]). Citropin 1.1 started at 189.94 µg/mg, up to 3.32 TFA per molecule for three basic sites (calculated from[4]).

Purity is not content: the glucagon mass balance
Wang et al. assigned a reference-grade glucagon by mass balance. LC-UV purity was 983.72 mg/g. TFA by ion chromatography was 103.03 mg/g, water by Karl Fischer 50.2 mg/g, and other inorganic ions by ICP-MS under 0.1%. The final assigned glucagon content was 896.36 mg/g[5]. Here a sample of roughly 98% purity was about 90% peptide. A lighter, more basic peptide would show a much larger gap.
Residual TFA in cell assays
The most-cited warning comes from Cornish et al. In fetal rat osteoblast cultures, TFA at 10−8 to 10−7 M reduced cell numbers and thymidine incorporation after 24 h. Similar effects were seen in articular chondrocytes and neonatal mouse calvariae. When TFA and hydrochloride salts of amylin, amylin-(1-8) and calcitonin were compared in osteoblasts, proliferation was consistently lower with the TFA salts. The authors note this can hide a proliferative effect or wrongly suggest an antiproliferative one, and recommend converting peptides used above 10−9 M to a hydrochloride or biologically equivalent salt[7]. We could read only the abstract of this paper, because the full text is not open access. The arithmetic shows why such low concentrations matter. A peptide at concentration C carrying n TFA puts n × C of TFA into the well (calculated). A 3-TFA peptide tested at 10 nM therefore adds 30 nM TFA, which falls inside the range Cornish reported.
The effect is not one-directional. Sikora et al. compared TFA, acetate and chloride salts of several antimicrobial peptides. The TFA salts generally had the weakest antistaphylococcal activity. Acetate was the least cytotoxic form for three peptides, but for temporin A the TFA salt was least toxic[3]. Hemolysis differed sharply: pexiganan acetate lysed 30.75% of erythrocytes at 256 µg/mL versus 7.04% for TFA and 8.51% for chloride[3]. Erckes et al. found that the effect of salt form on membrane permeation depended on the sequence[2]. The practical rule is to report the salt form and keep it constant within a comparison, rather than assuming any one salt is universally benign.
TFA also suppresses ionisation in electrospray mass spectrometry, so a TFA salt can weaken MS signals[1]. The mass spectrometry explainer covers what an MS result can and cannot show.
Exchanging the counter-ion: what the evidence shows

| Method | What the primary data show |
|---|---|
| HCl solution + lyophilisation | Erckes et al.: 10 mM HCl took AT1 below the 19F LoQ (<1% w/w) in one cycle, as did 100 mM; 2 mM needed three cycles and 5 mM two. Chloride reached 99% of stoichiometric, and purity stayed >96% with no degradation up to 100 mM[2]. Andrushchenko et al. studied one peptide, indolicidin, by IR and CD spectroscopy over three cycles. 1 mM HCl already removed the IR-visible TFA band. Structural changes appeared from 10 mM in unbuffered solution and 50 mM in buffered solution. They judged 2–10 mM, with three or more cycles, the safest range[8]. |
| 0.1 M HCl lyophilisation, repeated | Citropin 1.1: 87 mol% chloride after one cycle and 96% after four[4]. |
| HCl-saturated acetonitrile or tert-butanol | 98% chloride in a single cycle for citropin 1.1[4]; >97 mol% chloride across peptides in the 2018 activity study[3]. |
| Acetic acid lyophilisation | Described as far from satisfactory for citropin 1.1[4]. The review lists ion-exchange resin as the usual route to acetate[1]. |
| Acetate salt after formulation | CSP7 acetate fell from 1:1 to 0.30:1 acetate after lyophilisation without a non-volatile base, while TFA stayed at 0.81:1[6]. Acetate is volatile, so its content needs re-measuring after processing. |
Chloride is not automatically the better salt. The review notes that HCl exchange is harsher (pH below 1) than acetate exchange, and that salt affects stability case by case[1]. In Sikora et al., the LL-37 chloride salt was less stable than its TFA counterpart[3]. Peptide-specific salt discussions are in BPC-157 acetate vs arginate and GHK-Cu salt forms.
How counter-ions are measured
| Method | What it measures | Validated LoQ / notes |
|---|---|---|
| 19F NMR | TFA only. The CF3 singlet is near −75 ppm, and an internal standard gives a molar ratio[1][6] | 10.3 µg/mg (1.03% w/w)[2], about 0.07 TFA per Selank molecule (calculated) |
| HPLC-ELSD / CAD | TFA and other non-UV anions | 5.8 µg/mg (0.58% w/w)[2], the most sensitive in the validated comparison |
| Ion chromatography (IC) | TFA, acetate, chloride, phosphate and others in one run | Called the method of first choice in the review[1]; used in the glucagon mass balance[5] |
| Capillary electrophoresis (CE) | Small anions by indirect UV detection | Established for counter-ions including chloride and TFA[1] |
| FT-IR | TFA bands at 1670, 1200 and 1147 cm−1, overlapping amide I | 178 µg/mg (17.8% w/w)[2], useful for screening but not quantitative at relevant levels |
| 1H NMR | Acetate methyl near 1.75 ppm | Molar ratio to the peptide[6] |
| Elemental analysis / amino acid analysis | Fluorine or chlorine; AAA gives the peptide mass | Indirect; the basis for net peptide content |
What a COA should state
- The salt form by name (for example TFA, acetate or hydrochloride), not just the sequence and MW.
- Counter-ion content as % w/w, with the method (IC, 19F NMR, ELSD or CE) and its LoQ. ‘TFA removed’ should come with a number below a stated LoQ.
- Water content by Karl Fischer.
- Net peptide content and its basis (amino acid analysis, nitrogen, or mass balance), shown separately from HPLC purity.
- Whether the MW quoted is the free base or the salt.
- The batch number, tying these figures to the vial. See how to read a peptide COA and why stability claims are batch-specific.
Decision tree for a research use
- Is the work cell-based, or sensitive to proliferation, membranes or pH? If yes, ask for the counter-ion content and consider a chloride or acetate exchange. If no, a TFA salt is usually acceptable if it is documented.
- Does the assay rely on electrospray MS or IR? If yes, TFA can suppress the signal or overlap amide I, so measure it or exchange it.
- Are you comparing two lots or two suppliers? If yes, confirm both carry the same salt and normalise to net peptide content, not weighed mass.
- Is an acetate salt specified? Then ask how the acetate was measured and when. It can be lost on lyophilisation.
- Is the COA missing a counter-ion figure? Then treat the peptide content as unknown and quantify it (IC or 19F NMR) before calculating molar concentrations.
Myth vs evidence
| Myth | Evidence |
|---|---|
| The salt form does not affect activity. | TFA, acetate and chloride salts of the same peptide differed in antimicrobial activity, cytotoxicity and hemolysis[3], and TFA alone affected bone cells at nanomolar levels[7]. |
| 98% purity means 98% peptide. | Glucagon at 98.4% LC-UV purity was 89.6% peptide by mass[5]. |
| Counter-ion content equals the theoretical salt. | Excess TFA pushed AT1 to about 1.28× stoichiometric (calculated from[2]), while glucagon was below its charge maximum[5]. |
| Lyophilising from acetic acid gives an acetate salt. | Acetate exchange by lyophilisation was unsatisfactory for citropin 1.1[4]. Resin exchange is the usual route[1]. |
| Acetate salts are always more stable. | Acetate was lost on freeze-drying CSP7, with pH shift and aggregation[6]. Stability is case-specific[1]. |
| More HCl removes TFA better. | 10 mM matched 100 mM for AT1 in one cycle[2], and in indolicidin, unbuffered HCl at 10 mM and above altered the secondary structure[8]. |
Glossary
- Counter-ion: the anion paired with each protonated basic site of a peptide salt.
- TFA: trifluoroacetic acid or its anion, trifluoroacetate (CF3COO−).
- Net peptide content (NPC): the mass fraction of the solid that is peptide, after counter-ions, water and other non-peptide matter.
- HPLC purity: the target peak’s share of UV-absorbing peptide species. It ignores salts and water.
- Ion exchange: replacing one counter-ion with another, by repeated acid lyophilisation or on a resin.
- LoQ: limit of quantification, the lowest amount a validated method can measure reliably.
- ELSD/CAD: evaporative light-scattering or charged-aerosol detection, used for analytes without a UV chromophore.
Frequently asked questions
Why are most research peptides sold as TFA salts?
Trifluoroacetic acid cleaves the peptide from the resin in solid-phase synthesis and is used in the HPLC mobile phase. The purified peptide therefore carries trifluoroacetate on each protonated basic site unless a separate exchange step is done.
What is the difference between a TFA salt and an acetate salt?
The peptide is the same. Only the anion paired with its positive charges differs. Acetate is lighter, so an acetate salt contains more peptide per milligram, but it is also volatile and can be partly lost on freeze-drying.
How much of a peptide’s weight can be TFA?
Measured values of about 10–35% w/w have been reported. Our calculation for a full TFA salt ranges from about 14% for BPC-157 to 50% for GHK, depending on molecular weight and the number of basic sites.
Does residual TFA affect cell culture experiments?
It can. One study reported that TFA at 10–100 nM reduced osteoblast cell numbers in culture, with similar effects in chondrocytes. Other work shows salt effects vary by peptide and assay, so report the salt and keep it constant.
How is TFA removed from a peptide?
The usual approach is repeated lyophilisation from dilute HCl, where 10 mM removed TFA below quantification in one cycle in a validated study, or from HCl-saturated organic solvents. Acetate is usually introduced on an ion-exchange resin.
How is TFA content measured?
Quantitatively by 19F NMR, ion chromatography, HPLC with ELSD or CAD, or capillary electrophoresis. FT-IR is only a screen because its quantification limit is high.
Is HPLC purity the same as peptide content?
No. HPLC purity compares peptide-related peaks only. Net peptide content also subtracts counter-ions and water, which can make content 10 or more percentage points lower than purity.
Is an HCl salt better than an acetate or TFA salt?
Not universally. Chloride exchange is well documented, but stability and biological effects depend on the peptide. The right salt is the one that is documented and matched across a comparison.
What should a peptide COA say about the salt form?
It should name the counter-ion, give its content with the method and LoQ, and report water by Karl Fischer and net peptide content separately from HPLC purity.
Where to go next
Salt forms in practice: BPC-157 acetate vs arginate and GHK-Cu salt forms. Salts are not modifications; for terminal caps see Semax vs N-acetyl Semax amidate and Selank vs N-acetyl Selank amidate. The wider map is in the peptide identity hub, and certificate reading in how to read a peptide COA.
References
- Sikora K, Jaśkiewicz M, Neubauer D, Migoń D, Kamysz W. The role of counter-ions in peptides: an overview. Pharmaceuticals 2020;13:442
- Erckes V, Streuli A, Chamera Rendueles L, Krämer SD, Steuer C. Towards a consensus for the analysis and exchange of TFA as a counterion in synthetic peptides and its influence on membrane permeation. Pharmaceuticals 2025;18:1163
- Sikora K, Jaśkiewicz M, Neubauer D, et al. Counter-ion effect on antistaphylococcal activity and cytotoxicity of selected antimicrobial peptides. Amino Acids 2018;50:609–619
- Sikora K, Neubauer D, Jaśkiewicz M, Kamysz W. Citropin 1.1 trifluoroacetate to chloride counter-ion exchange in HCl-saturated organic solutions: an alternative approach. Int J Pept Res Ther 2018;24:265–270
- Wang X, Zhang F, Li H, et al. Purity determination of synthetic glucagon using a mass balance approach. Sci Rep 2020;10:4423
- Sahakijpijarn S, Moon C, Koleng JJ, Williams RO. Formulation composition and process affect counterion for CSP7 peptide. Pharmaceutics 2019;11:498
- Cornish J, Callon KE, Lin CQ, et al. Trifluoroacetate, a contaminant in purified proteins, inhibits proliferation of osteoblasts and chondrocytes. Am J Physiol 1999;277:E779–E783 (abstract only; full text not open access)
- Andrushchenko VV, Vogel HJ, Prenner EJ. Optimization of the hydrochloric acid concentration used for trifluoroacetate removal from synthetic peptides. J Pept Sci 2007;13:37–43
- PubChem CID 6422: trifluoroacetic acid (C2HF3O2, 114.02 g/mol)
- PubChem CID 176: acetic acid (C2H4O2, 60.05 g/mol)
Research Use Only Disclaimer
This article is for laboratory and analytical education only. The compounds discussed are research chemicals for in-vitro research use only (RUO). They are not drugs, foods, supplements or cosmetics and are not for human or animal use. Nothing here is medical advice, a protocol for administration, or a claim about any effect. Cell, animal and analytical literature is cited for scientific context only.